Safety and efficacy of bendamustine use in patients with chronic lymphocytic leukaemia

被引：0
|
作者：
Lam, J. H. P. [1 ]
Corbett, T. [1 ]
机构：
[1] Brighton & Sussex Univ Hosp NHS Trust, Royal Sussex Cty Hosp, Dept Haematol, Brighton, E Sussex, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 169卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
151
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients
    Gogia, Ajay
    Gupta, Ritu
    Sharma, Atul
    Kumar, Lalit
    Rani, Lata
    Mallick, Saumyaranjan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2023, 39 (01) : 33 - 39
  • [2] Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients
    Ajay Gogia
    Ritu Gupta
    Atul Sharma
    Lalit kumar
    Lata rani
    Saumyaranjan Mallick
    Indian Journal of Hematology and Blood Transfusion, 2023, 39 : 33 - 39
  • [3] Safety and efficacy of bendamustine and rituximab (BR) regimen in Indian chronic lymphocytic leukemia patients
    Gogia, A.
    Kumar, L.
    Sharma, A.
    Raina, V.
    Gupta, R.
    Rani, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Safety and efficacy of of atumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia
    Dyer, Martin J. S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (04) : 199 - 207
  • [5] Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison
    Andrasiak, Iga
    Rybka, Justyna
    Knopinska-Posluszny, Wanda
    Wrobel, Tomasz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (05): : 268 - 273
  • [6] Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia
    Robak, Tadeusz
    Hellmann, Andrzej
    Kloczko, Janusz
    Loscertales, Javier
    Lech-Maranda, Ewa
    Pagel, John M.
    Mato, Anthony
    Byrd, John C.
    Awan, Farrukh T.
    Hebart, Holger
    Garcia-Marco, Jose A.
    Hill, Brian T.
    Hallek, Michael
    Eisenfeld, Amy J.
    Stromatt, Scott C.
    Jaeger, Ulrich
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 618 - 628
  • [7] The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia
    Eyre, Toby A.
    Roeker, Lindsey E.
    Fox, Christopher P.
    Gohill, Satyen H.
    Walewska, Renata
    Walter, Harriet S.
    Forconi, Francesco
    Broom, Angus
    Arumainathan, Arvind
    Brander, Danielle M.
    Allan, John N.
    Schuster, Stephen J.
    Hill, Brian T.
    Lansigan, Frederick
    Cheson, Bruce D.
    Lamanna, Nicole
    Coombs, Catherine C.
    Barr, Paul M.
    Skarbnik, Alan P.
    Shadman, Mazyar
    Ujjani, Chaitra S.
    Pearson, Laurie
    Pagel, John M.
    Jacobs, Ryan
    Mato, Anthony R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (06) : 918 - 923
  • [8] Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
    Ali, Sharmila Binte Shamshad
    INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE, 2013, 11 (02): : 145 - 146
  • [9] Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
    Vidal, Liat
    Gafter-Gvili, Anat
    Gurion, Ronit
    Raanani, Pia
    Dreyling, Martin
    Shpilberg, Ofer
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [10] Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review
    Al-Sawaf, Othman
    Cramer, Paula
    Goede, Valentin
    Hallek, Michael
    Pflug, Natali
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (06) : 197 - 205
12345